Back to all companies
Sign in
Back to all companies
BillionToOne logo

BillionToOne

Summer 2017Public

The genetic testing platform detecting and measuring disease.

Save
BillionToOne logo

BillionToOne

Summer 2017Public

The genetic testing platform detecting and measuring disease.

Save
Company details

BillionToOne has developed a DNA molecular counter that increases the cell-free DNA diagnostics resolution by over 1,000 fold, which unlocks transformative improvements in prenatal screening and liquid biopsy for cancers. Unity Screen, BillionToOne's commercially available non-invasive prenatal test (NIPT), is the only NIPT that can assess fetal risk for both recessive conditions and aneuploidies from maternal blood. UNITY Screen continues to grow exponentially and is on its path to becoming the next standard-of-care, with an increasing number of publications showing its accuracy and advantages over other screening methods. We have also recently used our molecular counting technology to develop liquid biopsy tests, which have the potential to completely transform oncology care.

Location
San Francisco, CA, USA; Menlo Park, CA, USA
Founded
Unknown
Category
Diagnostics
YC Directory Pagewww.billiontoone.com
Founders
  • OA
    Oguzhan Atay
    Founder
    LinkedIn
  • DT
    David Tsao
    Founder/CTO
    LinkedIn

BillionToOne has developed a DNA molecular counter that increases the cell-free DNA diagnostics resolution by over 1,000 fold, which unlocks transformative improvements in prenatal screening and liquid biopsy for cancers. Unity Screen, BillionToOne's commercially available non-invasive prenatal test (NIPT), is the only NIPT that can assess fetal risk for both recessive conditions and aneuploidies from maternal blood. UNITY Screen continues to grow exponentially and is on its path to becoming the next standard-of-care, with an increasing number of publications showing its accuracy and advantages over other screening methods. We have also recently used our molecular counting technology to develop liquid biopsy tests, which have the potential to completely transform oncology care.

Location
San Francisco, CA, USA; Menlo Park, CA, USA
Founded
Unknown
Category
Diagnostics
YC Directory Pagewww.billiontoone.com
Founders
  • OA
    Oguzhan Atay
    Founder
    LinkedIn
  • DT
    David Tsao
    Founder/CTO
    LinkedIn
Pro

Upgrade to Pro, then request the BillionToOne teardown.

This company does not have a completed analysis yet. Choose a Pro plan first, then use one of your 5 monthly research requests to have our agent investigate BillionToOne. The full teardown, rebuild plan, and technical specs unlock when it lands.

  • Use Pro to request the first BillionToOne teardown and keep the finished report in your account.
  • Read every completed teardown and rebuild plan already in the database.
  • Unlock implementation-ready technical specs and 5 fresh research requests each month.

Choose your Pro plan

$20/ month

Find one worth rebuilding, get the teardown, open the implementation-ready specs, and use fresh report requests when you want deeper research.

See Pro plans
Full teardown library
Specs for every company
5 fresh requests / month
CLI for agent imports
Startups.RIP — Dead startups, alive ideas
PricingContactPrivacyGot feedback? DM @oscrhong